Roy Den Hollander was found dead two hours from the site of the New Jersey attackThe post Suspect In Slaying Of Federal Judge’s Son Was Columbia MBA appeared first on Poets&Quants. …read more […]
The healthcare sector took its place among the winners this year, rising 21%, compared to the S&P 500’s 0.5% growth. The bottom-line for investors? Wall Street’s focus is on the healthcare space, locking in on biotechs in particular.It should be noted that these stocks are risky in nature, with their shares prone to explosive movements on account of only a few key catalysts like updates on clinical studies or regulatory approvals. The good news is that a favorable outcome can drive massive share price appreciation. However, the bad news is that the opposite holds true.Given this volatility, it can be …read more […]
(Bloomberg) — WeWork cofounder Adam Neumann is seeking a buyer for his 11-acre property in Corte Madera, California, after paying $21.4 million for the estate in 2018.The home, located about 15 miles north of San Francisco, will be listed at $27.5 million, according to a person familiar with the matter, who requested anonymity because the deliberations are private.A spokesman for Neumann confirmed the potential sale.Neumann amassed multiple homes across the U.S., including New York, when WeWork was one of the most valuable startups on the planet. Now he’s entangled in a legal battle with SoftBank Group Corp. after the Japanese …read more […]
With the U.S. coronavirus case count zeroing in on 4 million, health experts ramped up their calls for a stronger federal leadership. …read more […]
(Bloomberg) — As the old stock market adage has it, buy the rumor, sell the fact. For investors who bought shares of Denbury Resources Inc. early Monday, it might be buy the fake news release, sell on the official denial.At 5:51 a.m. New York time, a statement carried by press release service Accesswire and purporting to be from the Texan oil driller said the company received a takeover offer at $1.20 a a share.Denbury’s stock more almost tripled in pre-market trading, only to pare those gains after CEO Chris Kendall told Bloomberg News the release was “completely fraudulent.” The company …read more […]
Wells Fargo Asset Management Multi-Asset Strategist Brian Jacobsen joins Yahoo Finance’s Akiko Fujita to discuss what to expect from upcoming earnings. …read more […]
Shares in AstraZeneca (AZN) dropped 3.5% even after early-stage human trial data from its Covid-19 vaccine candidate showed “robust” immune responses.The stock declined to $58.96 in afternoon market trading. Interim data results from the ongoing Phase I/II trial of the potential coronavirus vaccine, also known as AZD1222, which AstraZeneca is developing with Oxford University, showed “strong” antibody and immune T-cell responses.“While there is more work to be done, today’s data increases our confidence that the vaccine will work and allows us to continue our plans to manufacture the vaccine at scale for broad and equitable access around the world,” said …read more […]
Over the last few years – and certainly since the March crash – tech stocks have been on a tear. However, veteran tech giant IBM (IBM) has found it difficult to keep up, and has lagged behind the whole market. Yet, with F2Q earnings due today after market close, could sentiment be changing?With the Street calling for a year-over-year drop of 35% to revenue of $17.7 billion and EPS to decline by 8% to $2.07, Merrill Lynch analyst Wamsi Mohan argues the low expectations could provide IBM with a minor victory when it releases its quarterly statement this evening.Mohan said, …read more […]
Both calls and puts are being order up at an unusual rate today …read more […]
Columbia University’s Dr. Bernard Chang joins Yahoo Finance’s Zack Guzman to discus the recent coronavirus developments as cases surge in Florida and California. …read more […]
(Bloomberg) — Silver futures are latching on to gold’s rally, climbing above $20 an ounce to the highest since 2016 on rising haven demand and concerns about supply of the white metal.Gold and silver have surged this year as the coronavirus pandemic roiled the global economy, spurring sustained demand for havens even as some lockdowns were eased. The outbreak has yet to be brought under control in many countries including the U.S., bolstering the case for holding the metals.Silver, which just completed its best quarter since 2010, is getting an extra boost from concerns about supply and bets on increased …read more […]
The markets face two big risks amid the COVID-19 pandemic, says Tom Essaye, founder of the Sevens Report Research. …read more […]
(Bloomberg) — AstraZeneca Plc fell from a record high in New York trading after data for the company’s Covid-19 vaccine candidate, though promising, fueled concerns about whether it can match competitors.Bernstein analysts led by Ronny Gal said the vaccine, developed in partnership with the University of Oxford, showed early positive data, but the benefits didn’t appear to match the bar set by programs from Pfizer Inc. and BioNtech SE, as well as Moderna Inc.“In the competitive context they fail to impress,” Gal wrote.Exacerbating concerns, the Lancet medical journal publication came just an hour after Pfizer and BioNtech had announced early …read more […]
Convinced of Tesla Inc’s imminent meteoric rise, Orestis Palampougioukis, a Netherlands-based software developer, took out a 43,000 euro ($49,000) loan in early October to invest it all in the electric carmaker, which at the time was trading at around $230 a share. Since then, Palampougioukis’ bet has paid off as Tesla’s share price has increased more than six-fold, trading around $1,500 on Monday and surpassing every rival to become the world’s highest-valued automaker. “To me it didn’t feel like a bet because I studied what Tesla does very closely and it’s simply inevitable that it would …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
